Paper Details

  1. Home
  2. Paper Details

[Quality of life and tolerance of maintenance therapy in patients with multiple myeloma].

Author: , AdamZ, BacovskýJ, BencíkováV, BüchlerT, CahováS, DostálováV, DusekL, FrankováH, GumulecJ, HájekR, KesslerP, KozaV, KrejcíM, LehankaF, MeluzínováI, NykodýmováV, PourL, SalajkaF, SchützováM, ScudlaV, SeifertováN, SlámaO, StavarováY, SumnáE, SvobodníkA, VránováM, VytrasováM, WalterováL

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Maintenance treatment for multiple myeloma using interferon alpha or a combination of interferon alpha and dexamethasone was associated with several undesirable side effects, including vision problems, sleep disturbances, depression, and muscle and joint pain. Patients reported a lower quality of life compared to healthy individuals.
Paper Details　
Original Abstract of the Article :
Questionnaires on the quality of life and tolerance of different parts of maintenance treatment were sent to a total of 83 patients with multiple myeloma. All patients were for more than one year on maintenance treatment which involved either interferon alpha monotherapy (I), 3 million u. three time...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/11968583

データ提供：米国国立医学図書館（NLM）

Quality of Life and Tolerance of Maintenance Therapy in Multiple Myeloma Patients: Navigating the Challenges of Treatment

This study investigates the quality of life and tolerance of maintenance therapy in patients with multiple myeloma. The authors analyze the experiences of 83 patients who received maintenance therapy with either interferon alpha or a combination of interferon alpha and dexamethasone. The study highlights the importance of addressing the potential side effects and impact on quality of life associated with these treatments, emphasizing the need for careful monitoring and personalized care. The authors also discuss the importance of involving patients in treatment decisions and considering their perspectives on quality of life.

Quality of Life in Multiple Myeloma: A Journey Through the Desert of Treatment

This study examines the challenges faced by patients with multiple myeloma undergoing maintenance therapy. The researchers analyze the impact of these treatments on quality of life and tolerance, highlighting the need for individualized care and patient-centered approaches. It's like navigating a vast desert of treatment, where patients need to be guided and supported to find their way through the complexities of managing their condition.

Living With Multiple Myeloma: Prioritizing Quality of Life

The results of this study emphasize the importance of considering quality of life as a key factor in managing multiple myeloma. Patients should actively participate in treatment decisions and discuss their concerns and preferences with their healthcare providers. It's essential to prioritize quality of life and find a balance between disease management and overall well-being. Remember, just like a camel adapts to the harsh desert environment, you need to find ways to manage your condition and maintain a fulfilling life.

Dr. Camel's Conclusion

This study provides valuable insights into the quality of life and tolerance of maintenance therapy in patients with multiple myeloma. The findings highlight the importance of addressing the potential side effects of these treatments and considering the perspectives of patients. It's a reminder that managing multiple myeloma requires a holistic approach, focusing on both disease control and the well-being of the patient. Just like a camel navigating the desert, patients with multiple myeloma need to be resourceful and adaptable in managing their condition and maintaining a good quality of life.
Date :
  1. Date Completed 2002-05-09
  2. Date Revised 2018-11-30
Further Info :

Pubmed ID

11968583

DOI: Digital Object Identifier

11968583

Related Literature

Article Analysis
・Effective treatment of multiple myeloma
SNS
PICO Info
in preparation
Languages

Czech

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.